Episode 186 - June 12, 2026

Episode 186 - June 12, 2026

From Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

June 12, 2026 · 1h 1m

About this episode

The episode discusses the current state of the biotech market, recent IPOs, financings, and significant acquisitions in the industry.

On this week’s episode, Graig Suvannavejh, Eric Schmidt, Paul Matteis and Financial Times’ Oliver Barnes kicked off with the biotech market, with the XBI in positive territory and 12 biotech IPOs completed so far this year. They expected the IPO window to remain open for high-quality private companies. The group also overviewed recent financings, including SonoThera’s $125 million Series B, City Therapeutics’ $100 million Series B, Ethyreal’s $101 million Series A, and Summit’s decision to cancel a $500 million secondary offering. In data news, the co-hosts covered Tango’s combination data with Revolution Medicines’ RAS inhibitor. They also discussed Incyte’s acquisition of Vega Therapeutics as a pipeline-building move ahead of Jakafi’s 2028 patent expiration and J&J’s acquisition of Firefly, with the RAS inhibitor space expected to remain hot. The group also discussed GSK’s acquisition of Nuvalent -- its largest deal to date -- for two late-stage lung cancer assets. Oliver added perspective on biotech deal leaks, following the Incyte/Vega deal and GSK/Nuvalent deals this week. In partnership updates, Novartis expanded its molecular glue work with Orionis, Lilly licensed an…

People in this episode

Guests: Graig Suvannavejh, Eric Schmidt, Paul Matteis, Oliver Barnes

Topics covered

  • biotech market
  • IPO activity
  • financings
  • acquisitions
  • rare disease
  • gene therapy

Keywords

  • biotech
  • IPO
  • financing
  • acquisition
  • gene therapy
  • rare disease
  • RAS inhibitor

Mentioned in this episode

Organizations: Financial Times, SonoThera, City Therapeutics, Ethyreal, Summit, Tango, Revolution Medicines, Incyte, Vega Therapeutics, J&J

Places: China

More episodes of Biotech Hangout

Explore listener stats, chart rankings, contacts and more on the Biotech Hangout podcast page.